Patients with severe COVID-19 who require venovenous extracorporeal membrane oxygenation (VV-ECMO) support can, if carefully selected and managed, obtain “exceptional survival” approaching 87% at 1 ...
Respiratory and survival outcomes in the year after receiving extracorporeal membrane oxygenation (ECMO) for severe COVID-19 were excellent in a highly selected group treated at one New York City ...
Early application of prone positioning did not help patients with severe acute respiratory distress syndrome (ARDS) -- mostly from COVID -- get off venovenous extracorporeal membrane oxygenation ...
Please provide your email address to receive an email when new articles are posted on . Packed red blood cell transfusion improved survival among adults with acute respiratory distress syndrome on ...
Some patients with severe COVID-19 who are treated with extracorporeal membrane oxygenation (ECMO) may experience significant lung recovery and return to normal lives with 'meaningful' long-term ...
Please provide your email address to receive an email when new articles are posted on . A high effort to eliminate carbon dioxide was linked to a greater likelihood of failing to wean from venovenous ...
A notable proportion of patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure developed acute kidney injury (AKI), likely due to the greater severity ...
Neonates were monitored with a cerebral oximeter before, during, and after cannulation for ECMO to determine the direct effects of ligation of the right internal jugular vein and right carotid artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results